Description: The Society of Actuaries (SOA) published its first COVID-19 research brief on March 10, 2020, followed by regular updates and expansions through June 12, 2020. The comprehensive report included a section of statistics that highlight the pandemic’s impact on economies in the U.S. and Canada. This report shows updates through September 30, 2020, to selected graphs from the Economic and Asset Impact section of the comprehensive report.

Description: Cover a variety of topics centered around the unsupervised learning technique called 'clustering'. The presenters will take you through a wide array of topics that range from 'What is Clustering?' to 'How can I use this technique to solve problems I didn't even know existed?' In the health care industry, everyone is looking for an edge in reducing total spend-cluster analysis finds the unambiguous in an ambiguous framework of results.

Description: Hear about the new hope biosimilars bring in helping payers and patients manage the rapidly growing pharmacy spend. The Big Event, encompassing multiple Humira biosimilars, launches in 2023 and could set the tone for how much biosimilars can be expected to contribute to solving our pharmacy spend challenges. What will be the financial impact of the Big Event and this coming wave? What can be done to maximize adoption of biosimilars? What strategies are available to maximize savings for payers and patients?

Description: High inflation rates can affect disability insurance in a variety of ways. Learn about rising price and wage inflation trends and why they are of interest to disability insurers. You will also hear presenters address topics such as recessionary pressures, the eroding value of benefits, wage growth, top-line trends and expense pressures. By attending the session, you will gain insight into how inflation should be considered in pricing, reserving and financial modeling.

Description: Dive into a summary focused on the discussion from the Health Section's Pharmacy Partnership Forum in March 2023 entitled 'Reimagining Pharmacy Financing' where a multi-disciplinary group of clinicians, health economists, academics, and actuaries met and discussed the following questions: - How do we define the value of prescription drugs? - How do we measure the value of prescription drugs? - How do we scalably and meaningfully apply the answers?

Description: This tool created graphs of Google's mobility Data. This version of the tool contains state-level U.S. data through July 31, 2020

Description: It happens every year: hurricanes, wildfires, and floods destroy property, interrupt routine care, and exacerbate chronic conditions. Clearly, general insurance and health actuaries need to reflect these conditions in their pricing projections even though there are lots of unanswered questions about the frequency, intensity, and location of significant events. In this session, the presenters will discuss how to reflect the impact of climate change in the day-to-day work of health and general insurance actuaries. After this session, attendees will be able to: - Describe the impact of climate change on property damage and healthcare - Identify relevant data sources and methods needed to reflect the impact of climate change for use in the day-to-day work of health and general insurance actuaries - Discuss the risk associated with climate change

Description: Healthcare cost trends remain a cornerstone of actuarial practice and forecasting for employer-sponsored health plans. This session will examine recent and emerging healthcare drivers of medical and prescription drug trends using data and methodologies drawn from two research efforts focusing on projecting trends and total cost of care.

Description: This is an article that highlights recommended reading by the Health Practice area communications committee. The readings cover a broad subject matter from risk assessment, medical technology to uninsured.

Description: El webcast presentará una comparación de alto nivel de los acuerdos internacionales de financiamiento de la atención de la salud y proporcionará una comparación y contrato con los modelos de Colombia y otros modelos latinoamericanos.